Profile
Epidarex Capital is a leading transatlantic venture capital firm that invests in early-stage, high growth life science opportunities in under-ventured markets. Epidarex funds ground-breaking research, often building companies from scratch, to address large unmet medical needs with solutions that provide significant benefits to patients.
Industry
Epidarex Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Epidarex Capital II
|
Venture Capital (VC)
|
Financial Services
Fintech
Healthcare Services
HealthTech
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$47 M
|
May 2014
|
|
Epidarex Capital III
|
Venture Capital (VC)
|
Financial Services
Fintech
Healthcare Services
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$105 M
|
June 2020
|
|
Epidarex Capital IV
|
Venture Capital (VC)
|
Financial Services
Fintech
Healthcare Services
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$110 M
|
January 2026
|
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for Epidarex Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about Epidarex Capital
Is Epidarex Capital a venture capital or private equity firm?
Epidarex Capital is a venture capital and private equity firm. It backs companies at Series A, Seed and Late Stage (Series C+), writing tickets of $50-100 m.
Where is Epidarex Capital located?
Epidarex Capital is located in Bethesda, Maryland, United States.
When was Epidarex Capital founded?
Epidarex Capital was founded in 2010.
What sectors and industries does Epidarex Capital invest in?
Epidarex Capital invests in companies and startups in Biotechnology, Fintech, Healthcare Services, Medical Devices, Pharmaceuticals, Financial Services, MedTech, Technology, Life Sciences, Infrastructure, HealthTech.
What is Epidarex Capital geographical focus of investments?
Epidarex Capital invests in companies and startups in North America, Europe.
At what stages of companies and startups does Epidarex Capital typically invest in?
Epidarex Capital invests in companies and startups at Series A, Seed, Late Stage (Series C+).
What is the usual amount of Epidarex Capital investment?
Epidarex Capital usually invests $50-100 m on average.
What is the amount of assets of under management (AUM) for Epidarex Capital?
Epidarex Capital has around $395m assets under management.
When was Epidarex Capital last fund created?
Epidarex Capital last fund was created/launched in 2026-01-27
What are the contacts of Epidarex Capital?
Epidarex Capital can be reached through its website epidarex.com, its LinkedIn page and its X account. Its general enquiries address is info@epidarex.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Epidarex Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access Epidarex Capital data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Epidarex Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the Epidarex Capital profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 09 April, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.